Fate Therapeutics Inc. (FATE)
NASDAQ: FATE
· Real-Time Price · USD
1.09
0.02 (1.87%)
At close: Aug 15, 2025, 3:59 PM
1.14
4.11%
After-hours: Aug 15, 2025, 07:57 PM EDT
Fate Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 8.47M | 13.34M | 13.63M | 13.45M | 12.32M | 6.48M | 63.53M | 106.21M | 119.25M | 136.87M | 96.3M | 69.01M | 68.25M | 63.12M | 55.85M | 54.67M | 48.01M | 40.06M |
Cost of Revenue | 7.88M | 9.33M | 14.15M | 19.03M | 19.17M | 18.91M | 18.28M | 18.24M | 16.69M | 93.53M | 161.48M | 226.15M | 276.09M | 242.81M | 215.52M | 184.99M | 162.55M | 141.2M |
Gross Profit | 5.19M | 8.61M | 4.09M | -980K | -6.85M | -12.43M | 45.25M | 87.97M | 102.56M | 43.33M | -65.18M | -157.14M | -207.84M | -179.69M | -159.67M | -130.31M | -114.54M | -101.14M |
Operating Income | -192.37M | -200.49M | -210.28M | -196.6M | -195.5M | -212.99M | -190.51M | -206.85M | -241.97M | -262.51M | -308.39M | -313.35M | -281.58M | -245.25M | -216.99M | -181.01M | -157.88M | -139.8M |
Interest Income | 14.57M | 16.48M | 17.29M | 17.83M | 18.09M | 17.64M | 17.19M | 15.65M | 12.74M | 9.12M | 5.84M | 3.26M | 1.76M | 1.35M | 1.31M | 1.36M | 1.51M | 1.8M |
Pretax Income | -171.52M | -175.88M | -186.26M | -178.23M | -175.72M | -190.05M | -160.93M | -173.17M | -211.56M | -234.91M | -281.72M | -293.98M | -253.72M | -232.75M | -212.15M | -196.64M | -212.02M | -184.96M |
Net Income | -171.52M | -175.88M | -186.26M | -178.23M | -175.72M | -190.05M | -151.22M | -155.4M | -190.97M | -214.32M | -262.06M | -282.37M | -244.95M | -223.97M | -212.15M | -196.64M | -212.02M | -184.96M |
Selling & General & Admin | 61.28M | 67.09M | 74.17M | 76.84M | 74.99M | 80.36M | 81.45M | 85.1M | 87.7M | 85.43M | 84.23M | 79.58M | 73.75M | 65.56M | 57.32M | 50.7M | 43.33M | 38.67M |
Research & Development | 124.83M | 132M | 135M | 133.21M | 132.83M | 139.1M | 172.6M | 227.97M | 273.51M | 313.94M | 320.45M | 302.78M | 276.09M | 242.81M | 215.52M | 184.99M | 162.55M | 141.2M |
Other Expenses | 14.74M | 10.02M | 5.2M | -14.43M | -19.17M | -14.45M | -9.63M | 436K | 6.22M | 12.46M | 20.82M | 15.65M | 14.61M | 8.36M | n/a | n/a | n/a | n/a |
Operating Expenses | 200.84M | 209.1M | 214.37M | 195.62M | 188.66M | 205.02M | 244.42M | 308.33M | 361.22M | 399.38M | 404.69M | 382.36M | 349.84M | 308.37M | 272.84M | 235.69M | 205.88M | 179.86M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 200.84M | 213.82M | 223.91M | 210.05M | 207.82M | 219.47M | 254.04M | 313.07M | 361.22M | 399.38M | 404.69M | 382.36M | 349.84M | 308.37M | 272.84M | 235.69M | 205.88M | 179.86M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -9.71M | -17.77M | -20.59M | -20.59M | -19.66M | -11.61M | -8.78M | -8.78M | n/a | -861K | -861K | -861K |
Shares Outstanding (Basic) | 118.53M | 118.38M | 117.79M | 117.77M | 117.47M | 101.1M | 98.61M | 98.57M | 98.4M | 98.05M | 97.22M | 97.02M | 96.7M | 96.34M | 95.79M | 95.41M | 94.33M | 93.43M |
Shares Outstanding (Diluted) | 118.53M | 118.38M | 117.79M | 117.77M | 117.47M | 101.1M | 98.61M | 98.57M | 98.4M | 98.05M | 97.22M | 97.02M | 96.7M | 96.34M | 95.79M | 95.41M | 94.33M | 93.43M |
EPS (Basic) | -1.45 | -1.49 | -1.64 | -1.65 | -1.71 | -1.92 | -1.54 | -1.59 | -1.96 | -2.21 | -2.71 | -2.93 | -2.55 | -2.34 | -2.23 | -2.12 | -2.35 | -2.12 |
EPS (Diluted) | -1.45 | -1.49 | -1.64 | -1.65 | -1.71 | -1.92 | -1.54 | -1.59 | -1.96 | -2.21 | -2.71 | -2.93 | -2.55 | -2.34 | -2.23 | -2.12 | -2.35 | -2.12 |
EBITDA | -164.88M | -168.28M | -176.58M | -177.57M | -176.34M | -194.07M | -172.23M | -188.62M | -225.28M | -247.32M | -294.63M | -301.47M | -271.37M | -236.84M | -210.38M | -196.22M | -173.83M | -156.17M |
EBIT | -174.74M | -185.75M | -195.54M | -196.6M | -195.5M | -212.99M | -190.51M | -206.85M | -241.97M | -262.51M | -308.39M | -312.59M | -280.82M | -244.49M | -216.23M | -200.72M | -177.59M | -159.51M |
Depreciation & Amortization | 16.03M | 17.47M | 18.96M | 19.03M | 19.17M | 18.91M | 18.28M | 18.24M | 16.69M | 15.19M | 13.76M | 11.12M | 9.45M | 7.65M | 5.85M | 4.5M | 3.76M | 3.34M |